cannareviews logo icon

canna

reviews

Sign in required

Validation required for access - please validate your medAuth account . If already validated, please sign out of Canna Reviews, and sign back in again.
Alfie Therapeutics

Southern Sky Sativa 24% - 10g

Sativa Dominant High THC

Flower

PNW × Zkittles × Moonbow

THC 24%

CBD 1%

Category 5
Schedule 8
Finished Product
In Stock Updated: 11/12/25
$95 RRP
$9.5 g  /  $0.040 mg

This sativa-dominant cultivar (60/40) presents a balanced clinical profile with 2.76% total terpenes and notable contributions from beta-Caryophyllene (1.07%), alpha-Humulene (0.44%), Limonene (0.43%), alpha-Bisabolol (0.17%) and Linalool (0.16%). The chemotype reflects a consistent and stable expression typical of Southern Sky’s small-batch production standards.

Southern Sky Sativa 24% is grown indoors under fully optimised environmental controls, using an organic coco husk and soil mix with naturally derived nutrients. All flower is hand-picked and hand-trimmed to maintain consistent trichome structure and terpene profile.

Anecdotally, patients describe an energetic and uplifted onset, often noting improvements in creativity, mental clarity and general function.

Given the strength of effect, lower initial vaporisation temperatures and conservative titration are advised when initiating therapy.

Typical Dosing Times: Day + Evening
Lineage: PNW × Zkittles × Moonbow
Size: 10 g
Total Terpenes: 2.76% w/w
Flavour notes: Apple, woody, lavender

test community photo of Alfie Therapeutics Southern Sky Sativa 24% Flower 10g
community photo of Alfie Therapeutics Southern Sky Sativa 24% Flower 10g

Community photos

FEEDBACK AND PRODUCT INFORMATION ARE NOT TO BE TAKEN AS MEDICAL ADVICE, PROMOTION, ADVERTISEMENT OF, OR INDUCEMENT FOR THE USE OR SUPPLY OF MEDICAL CANNABIS FOR MEDICAL DIAGNOSIS OR TREATMENT. Cannabis may have side effects or interactions with other medications. Medical Cannabis is not effective for everyone and more research is needed. Please consult a health professional for advice. Information is submitted by patients and does not represent the views of this website. This website is not responsible for information that patients share of their own free will and accord. This website does not receive any compensation (financial or otherwise) for displaying product information.